As of 2024-07-27, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (15.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.72 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -1029.7%.
The range of the Relative Valuation is (16.02) - (16.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 31.9x | 31.8x |
| Forward P/E multiples | 27.9x - 31.0x | 30.1x |
| Fair Price | (16.02) - (16.01) | (15.99) |
| Upside | -1031.2% - -1030.6% | -1029.7% |
| Date | P/E |
| 2024-07-26 | -3.33 |
| 2024-07-25 | -3.06 |
| 2024-07-24 | -2.92 |
| 2024-07-23 | -3.21 |
| 2024-07-22 | -3.29 |
| 2024-07-19 | -3.17 |
| 2024-07-18 | -3.04 |
| 2024-07-17 | -3.37 |
| 2024-07-16 | -3.48 |
| 2024-07-15 | -3.19 |
| 2024-07-12 | -3.21 |
| 2024-07-11 | -3.12 |
| 2024-07-10 | -2.77 |
| 2024-07-09 | -2.81 |
| 2024-07-08 | -2.46 |
| 2024-07-05 | -2.57 |
| 2024-07-03 | -2.69 |
| 2024-07-02 | -2.69 |
| 2024-07-01 | -3.12 |
| 2024-06-28 | -3.35 |
| 2024-06-27 | -3.29 |
| 2024-06-26 | -3.21 |
| 2024-06-25 | -3.06 |
| 2024-06-24 | -3.15 |
| 2024-06-21 | -3.23 |
| 2024-06-20 | -3.14 |
| 2024-06-18 | -3.14 |
| 2024-06-17 | -3.17 |
| 2024-06-14 | -3.27 |
| 2024-06-13 | -3.45 |
| 2024-06-12 | -3.52 |
| 2024-06-11 | -3.35 |
| 2024-06-10 | -3.37 |
| 2024-06-07 | -3.27 |
| 2024-06-06 | -3.37 |
| 2024-06-05 | -3.50 |
| 2024-06-04 | -3.45 |
| 2024-06-03 | -3.41 |
| 2024-05-31 | -3.52 |
| 2024-05-30 | -3.64 |
| 2024-05-29 | -3.56 |
| 2024-05-28 | -3.64 |
| 2024-05-24 | -3.70 |
| 2024-05-23 | -3.89 |
| 2024-05-22 | -4.08 |
| 2024-05-21 | -4.03 |
| 2024-05-20 | -4.03 |
| 2024-05-17 | -4.10 |
| 2024-05-16 | -4.20 |
| 2024-05-15 | -4.22 |